The aesthetics industry is evolving at an ever faster rate, making staying up to date with the latest headlines a challenge at times. With new brand alliances forming, exciting new product launches and educational events to help practitioners keep up with the latest treatment innovations and techniques, you don't want to miss these major industry headlines in aesthetics!
1. Dermsquared & Advanced Dermatology Strategic Alliance
Dermsquared, the preeminent platform for dermatology professionals to enhance patient care, is pleased to announce a strategic alliance with Advanced Dermatology and Cosmetic Surgery (Advanced Dermatology).
Advanced Dermatology, a distinguished network of dermatology practices, is collaborating with Dermsquared, the foremost dermatology education, information, and services platform, to provide access to state-of-the-art personalized support for each of its clinicians via a digitally-enabled, proprietary platform. This centralized digital hub will house tailored educational content and tools to empower each clinician in delivering optimal patient care. The offerings will encompass in-person conference access, virtual live and on-demand programs, digital products, and other utilities facilitating bidirectional communication between offices to share best practices.
Dr. Matt Leavitt, Executive Chairman and Founder of Advanced Dermatology and Cosmetic Surgery, stated, "We believe this collaboration with Dermsquared will expedite our ability to address the critical needs of our clinicians seeking education, information, and innovative solutions to advance their patient care capabilities. In partnership with Dermsquared, Advanced Dermatology will leverage the extensive expertise of our dermatology professional community in service of our mission to elevate patient care."
Dermsquared is honored to utilize its comprehensive digital platform to provide customized content and services for the Advanced Dermatology community. Eric Bruno, CEO of HCEsquared, the management company of Dermsquared, affirmed, "We are committed to ensuring every clinician within Advanced Dermatology has access to the most pertinent educational information and tools at their disposal as they serve thousands of patients daily across the nation."
2. Lira Purely Clinical Tour: Latest & Greatest Peel Protocols
Introduced by the Masters of Peel Innovation, Lira Clinical, Purely Clinical presents a revolutionary approach to achieving remarkable outcomes by shifting from skin exfoliation to skin regeneration through advanced delivery mechanisms, potent bioactive ingredients, and cutting-edge resurfacing techniques. Register now to explore how Pure Peel, and Lira Clinical's Smart Peels, initiate transformation without triggering inflammation while enhancing skin hydration, dermal health, and delivering superior results. Are you ready for truly transformative skin care?
Featuring The Four Lira Clinical Founders: Brenda Cumming, RN, MEP-C, Anna D. Konstantin, LE, Francine Kagarakis, RMA, and Metaxia Dalikas, LE, all internationally acclaimed skincare experts eager to share their decades of dermatological and skin care expertise and experience with you.
The Purely Clinical Tour – 2024 Dates & Locations:
- DENVER, CO - Sept 23, 2024 (8:30 AM – 6:30 PM)
- HOUSTON, TX - Oct 21, 2024 (8:30 AM – 6:30 PM)
- PHILADELPHIA, PA - Nov 4, 2024 (8:30 AM – 6:30 PM)
Event Highlights:
- Professional networking with colleagues
- Understanding clinical skincare achieving measurable results
- Discover how melanin management is an essential part of clinical skincare
- The latest in trends, research and product development
- Interactive treatment experiences
- Certification & CEUs (when applicable)
3. Candela Matrix Pro RF FDA Clearance for Facial Wrinkles
Candela Corporation, a leading global medical aesthetic device company, has received FDA 510(k) clearance for its Matrix system's Matrix Pro RF microneedling applicator for treating facial wrinkles in patients with Fitzpatrick Skin Types I-IV. This innovative radiofrequency (RF) platform offers comprehensive skin treatments through three distinct RF energy modalities.
The Matrix Pro applicator utilizes short pulse RF microneedling to stimulate collagen and elastin production, reducing facial wrinkles. Its Depth Intelligence technology, real-time impedance monitoring, and ultra-thin microneedles deliver precise energy at multiple skin depths in a single insertion.
FDA clearance was based on a retrospective study of 32 subjects, demonstrating clinically meaningful improvement in facial wrinkle appearance. Notably, 94% of participants rated their outcomes as 'much improved' or 'very much improved.'
"Achieving FDA clearance using the Matrix Pro applicator for wrinkle reduction is a testament to our rigorous testing, clinical validation processes, and dedication to advancing outcomes through proven science and technology," said Geoffrey Crouse, Candela Chief Executive Officer. "This clearance provides healthcare providers and their patients with a reliable, clinically validated treatment option for facial wrinkles. Our Matrix Pro applicator with its expanded facial wrinkle indication, further combined with the unique treatment capabilities of the Sublime and Sublative applicators, exemplifies our unique approach, integrating state-of-the-art research and development of multi-modality solutions to deliver superior results."
This FDA clearance further solidifies Candela's position as an industry leader in providing cutting-edge solutions for skin health and rejuvenation.
"The advanced technology of the Matrix Pro applicator ensures minimal discomfort and downtime, making it a preferred choice for patients seeking quick and visible improvements," said Dr. Konika Schallen, Senior Vice President of Global Clinical Operations and Medical Director of Candela and the Candela Institute of Excellence (CIE). "In addition to serving as a skin tightening solution for aging patients, RF microneedling has promise in the expanding GLP-1 receptor agonist market. The Matrix system's ability to regenerate collagen has promise with addressing the loss of facial volume associated with rapid weight loss induced by these highly sought-after injectable medications."
4. JUVEDERM VOLUMA XC for Temple Hollowing
Allergan Aesthetics, an AbbVie company, heralds the nationwide release of JUVÉDERM VOLUMA XC for addressing temple hollowing. Following its March 2024 FDA approval, JUVÉDERM VOLUMA XC emerges as the pioneering hyaluronic acid (HA) filler sanctioned for treating moderate to severe temple hollowing in adults over 21.1,2 The JUVÉDERM Collection of Fillers, preferred by patients and providers alike, now offers the most comprehensive range of treatment indications to fulfill patients' aesthetic aspirations.2-7
"Since approval, our priority has been developing and implementing a comprehensive training protocol to ensure providers are well-equipped with the scientific knowledge necessary for temple area injections," stated Carrie Strom, President of Allergan Aesthetics and Senior Vice President at AbbVie. "We remain committed to providing thorough training for this treatment area, as we do for all Allergan Aesthetics products. We eagerly anticipate the exceptional results our customers will achieve by incorporating JUVÉDERM VOLUMA XC for temple treatments into their holistic facial approach."
As the most acclaimed filler collection in the U.S.,9* the JUVÉDERM Collection of Fillers boasts remarkable patient satisfaction. JUVÉDERM VOLUMA XC, a key component of the collection, delivers the following benefits when used in the temples:
- Natural-looking results: Approximately 90% of patients reported satisfaction with the natural appearance and feel of their temples three months post-treatment.2†
- Enduring improvement: Over 85% of patients noted overall aesthetic enhancement one month after treatment, with results persisting up to 13 months.11‡§
- High patient satisfaction: 98% of patients who received temple treatment would recommend it to others.2
- Proven safety profile: JUVÉDERM VOLUMA XC for temples demonstrates an acceptable safety profile and is approved for adults of all Fitzpatrick skin types over 21 years of age.10
"The eye area is the primary facial concern for patients,12 making temple treatment a crucial part of a comprehensive aesthetic plan. As a board-certified plastic surgeon, I've received advanced training for JUVÉDERM VOLUMA XC's approved use in temples," explained Christopher C. Surek, DO, FACS. "JUVÉDERM VOLUMA XC temple treatments create a balanced, youthful look.1 Its immediate lifting effect1 makes it ideal for patients seeking subtle, natural-looking enhancements."
JUVÉDERM VOLUMA XC for moderate to severe temple hollowing is the latest addition to the JUVÉDERM Collection of Fillers. This collection now offers six specially formulated, modified HA fillers addressing various aesthetic goals: JUVÉDERM VOLUMA XC, JUVÉDERM VOLBELLA XC, JUVÉDERM VOLLURE XC, JUVÉDERM Ultra Plus XC, JUVÉDERM Ultra XC and JUVÉDERM VOLUX XC.2-7
*Based on a survey of 12 consumer lifestyle publications, 2014-2022.9
† According to subject self-assessments in the clinical temple study.2,11
‡ With optimal treatment.11
§ Based on independent Evaluating Investigator (EI) and participant Global Aesthetic Improvement Scale (GAIS) assessments of the temples.11
